Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02526901 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Born in Guangzhou Cohort Study (BIGCS)

Study acronym: BIGCS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 26, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary completion date: Dec 31, 2023 to Dec 31, 2025v6
  2. Minor Re-verified, no change to tracked fieldsv5
  3. Notable Primary completion date: Dec 31, 2020 to Dec 31, 2023v4
  4. Notable Primary completion date: Dec 31, 2019 to Dec 31, 2020v3
  5. Minor Primary completion date: Dec 2019 to Dec 31, 2019
    • Study completion date: Dec 31, 2030
    • Start date: Feb 2012 to Feb 1, 2012
    v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Born in Guangzhou Cohort Study (BIGCS) was established to investigate the short- and long-term effects of exposure in early life on health consequences in Guangzhou, China. Data are collected regarding environmental, occupational and lifestyle exposures as well as health outcomes in later life. Biological samples including blood and tissue samples are also collected from the participants.
Trial Details
NCT Number NCT02526901
Lead Sponsor Guangzhou Women and Children's Medical Center
Collaborators: University of Birmingham
Conditions
(from sponsor)
Intrauterine Hyperglycemia, Pregnancy Outcomes, Neurodevelopment, Immune Development, Childhood Obesity, Host and Microbiome
Related terms Pediatric Obesity
Enrollment 30,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov